In the last 12 months, insiders at Aardvark Therapeutics, Inc. ($AARD) filed 46 transactions with the SEC: 13 open-market purchases totaling $23,874,984 and 0 sales totaling $0. Net insider sentiment: net buying.
Aardvark Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Decheng Capital Global Life Sciences Fund IV, L.P. (Not found) — 6 transactions totaling $20,000,000
- Cormorant Asset Management, LP (Not found) — 3 transactions totaling $3,000,000
- Lee Tien-Li (Chief Executive Officer) — 15 transactions totaling $701,522
- Sun Nelson (Chief Financial Officer) — 7 transactions totaling $251,640
- Jones Bryan (Chief Operating Officer) — 3 transactions totaling $5,300
View all SEC Filings for Aardvark Therapeutics, Inc. (AARD).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 9, 2026 | Lee Tien-Li | Chief Executive Officer | A | Stock option (right to buy) | 203851 | $0.00 | 203,851.0000 | 21,773,272 | 50.00% | 0.94% |
| Feb. 9, 2026 | Sun Nelson | Chief Financial Officer | A | Stock option (right to buy) | 70549 | $0.00 | 70,549.0000 | 21,773,272 | 50.00% | 0.32% |
| Feb. 9, 2026 | Jaiman Manasi | Chief Medical Officer | A | Stock option (right to buy) | 70549 | $0.00 | 70,549.0000 | 21,773,272 | 50.00% | 0.32% |
| Dec. 11, 2025 | Sun Nelson | Chief Financial Officer | P | Common Stock | 3000 | $14.40 | 108,484.0000 | 21,773,272 | 2.84% | 0.01% |
| Dec. 11, 2025 | Lee Tien-Li | Chief Executive Officer | P | Common Stock | 7000 | $14.49 | 3,025,641.0000 | 21,773,272 | 0.23% | 0.03% |
| Oct. 15, 2025 | Lee Tien-Li | Chief Executive Officer | M | Common Stock | 1229 | $4.24 | 3,018,641.0000 | 0 | 0.04% | 0.00% |
| Oct. 15, 2025 | Jones Bryan | Chief Operating Officer | M | Stock option (right to buy) | 1250 | $0.00 | 40,052.0000 | 0 | 3.03% | 0.00% |
| Oct. 15, 2025 | Jones Bryan | Chief Operating Officer | M | Common Stock | 1250 | $4.24 | 1,250.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2025 | Lee Tien-Li | Chief Executive Officer | M | Stock option (right to buy) | 1229 | $0.00 | 40,566.0000 | 0 | 2.94% | 0.00% |
| Sept. 15, 2025 | Lee Tien-Li | Chief Executive Officer | P | Common Stock | 6500 | $9.51 | 3,013,912.0000 | 0 | 0.22% | 0.00% |
| Sept. 15, 2025 | Lee Tien-Li | Chief Executive Officer | P | Common Stock | 3500 | $9.94 | 3,017,412.0000 | 0 | 0.12% | 0.00% |
| Sept. 12, 2025 | Lee Tien-Li | Chief Executive Officer | P | Common Stock | 5000 | $8.50 | 3,007,412.0000 | 0 | 0.17% | 0.00% |
| Sept. 11, 2025 | Lee Tien-Li | Chief Executive Officer | P | Common Stock | 6000 | $7.82 | 3,002,412.0000 | 0 | 0.20% | 0.00% |
| Sept. 10, 2025 | Lee Tien-Li | Chief Executive Officer | P | Common Stock | 9000 | $7.91 | 2,996,412.0000 | 0 | 0.30% | 0.00% |
| Sept. 9, 2025 | Sun Nelson | Chief Financial Officer | P | Common Stock | 6000 | $8.07 | 105,484.0000 | 0 | 6.03% | 0.00% |
| Aug. 28, 2025 | Lee Tien-Li | Chief Executive Officer | M | Stock option (right to buy) | 17209 | $0.00 | 41,795.0000 | 0 | 29.17% | 0.00% |
| Aug. 28, 2025 | Lee Tien-Li | Chief Executive Officer | M | Common Stock | 17209 | $4.24 | 2,987,412.0000 | 0 | 0.58% | 0.00% |
| June 11, 2025 | Lee Tien-Li | Chief Executive Officer | A | Stock option (right to buy) | 549534 | $0.00 | 549,534.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2025 | Chi Jeffrey | Not found | A | Stock Option (right to buy) | 61017 | $0.00 | 61,017.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2025 | Jaiman Manasi | Chief Medical Officer | A | Stock Option (right to buy) | 126999 | $0.00 | 126,999.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2025 | Baynes Roy D. | Not found | A | Stock Option (right to buy) | 30508 | $0.00 | 30,508.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2025 | Tong Victor Edward Jr | Not found | A | Stock Option (right to buy) | 61017 | $0.00 | 61,017.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2025 | Sun Nelson | Chief Financial Officer | A | Stock Option (right to buy) | 209826 | $0.00 | 209,826.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2025 | Jones Bryan | Chief Operating Officer | A | Stock Option (right to buy) | 122033 | $0.00 | 122,033.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2025 | Graf Susan E | Not found | A | Stock Option (right to buy) | 30508 | $0.00 | 30,508.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2025 | Sun Nelson | Chief Financial Officer | C | Series C Convertible Preferred Stock | 59332 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 14, 2025 | Cormorant Asset Management, LP | Not found | C | Common Stock | 800189 | $0.00 | 800,189.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2025 | Cormorant Asset Management, LP | Not found | P | Common Stock | 187500 | $16.00 | 987,689.0000 | 0 | 23.43% | 0.00% |
| Feb. 14, 2025 | Cormorant Asset Management, LP | Not found | C | Series C Convertible Preferred Stock | 6780810 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 14, 2025 | Sun Nelson | Chief Financial Officer | P | Common Stock | 10000 | $16.00 | 99,484.0000 | 0 | 11.18% | 0.00% |
| Feb. 14, 2025 | Sun Nelson | Chief Financial Officer | C | Common Stock | 7001 | $0.00 | 89,484.0000 | 0 | 8.49% | 0.00% |
| Feb. 14, 2025 | Lee Tien-Li | Chief Executive Officer | C | Series A Convertible Preferred Stock | 350002 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 14, 2025 | Lee Tien-Li | Chief Executive Officer | P | Common Stock | 16542 | $16.00 | 2,970,203.0000 | 0 | 0.56% | 0.00% |
| Feb. 14, 2025 | Lee Tien-Li | Chief Executive Officer | C | Common Stock | 41303 | $0.00 | 2,953,661.0000 | 0 | 1.42% | 0.00% |
| Feb. 14, 2025 | Vickers Venture Fund VI Pte Ltd | Not found | C | Series B Convertible Preferred Stock | 3503919 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 14, 2025 | Vickers Venture Fund VI Pte Ltd | Not found | C | Series A Convertible Preferred Stock | 13875429 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 14, 2025 | Vickers Venture Fund VI Pte Ltd | Not found | C | Common Stock | 413491 | $0.00 | 2,050,902.0000 | 0 | 25.25% | 0.00% |
| Feb. 14, 2025 | Vickers Venture Fund VI Pte Ltd | Not found | C | Common Stock | 1637411 | $0.00 | 1,637,411.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2025 | Chi Jeffrey | Not found | C | Series C Convertible Preferred Stock | 1130135 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 14, 2025 | Chi Jeffrey | Not found | C | Common Stock | 133364 | $0.00 | 133,364.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. | Not found | C | Series C Convertible Preferred Stock | 2825337 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 14, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. | Not found | C | Series C Convertible Preferred Stock | 19777363 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 14, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. | Not found | P | Common Stock | 625000 | $16.00 | 3,917,299.0000 | 0 | 18.98% | 0.00% |
| Feb. 14, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. | Not found | P | Common Stock | 625000 | $16.00 | 3,917,299.0000 | 0 | 18.98% | 0.00% |
| Feb. 14, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. | Not found | C | Common Stock | 333412 | $0.00 | 3,292,299.0000 | 0 | 11.27% | 0.00% |
| Feb. 14, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. | Not found | C | Common Stock | 2333887 | $0.00 | 3,292,299.0000 | 0 | 243.52% | 0.00% |